Activin receptor: Difference between revisions
Jump to navigation
Jump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 50: | Line 50: | ||
**[[4fao]] - hALK1 LBD + GDF-2 + SKR3<br /> | **[[4fao]] - hALK1 LBD + GDF-2 + SKR3<br /> | ||
**[[6sf1]], [[6sf3]] - hALK1 LBD + BMP10<br /> | **[[6sf1]], [[6sf3]] - hALK1 LBD + BMP10<br /> | ||
**[[3my0]] - hALK1 kinase domain +inhibitor<br /> | **[[3my0]] - hALK1 kinase domain + inhibitor<br /> | ||
*Activin receptor-like kinase 5 or Serine/threonine-protein kinase receptor R4 or ALK5 or TGF-beta receptor type 1 or TGFR-1 or SKR4 | |||
**[[5e8s]], [[1ias]] - hALK5 kinase domain<br /> | |||
**[[5e8u]], [[5e8t]] - hALK5 kinase domain (mutant)<br /> | |||
**[[2l5s]] - hALK5 LBD - NMR<br /> | |||
**[[3kfd]] - hALK5 LBD + TGFR-2 LBD + TGF-beta-1<br /> | |||
**[[2pjy]] - hALK5 LBD + TGFR-2 LBD + TGF-beta-3<br /> | |||
**[[2wot]], [[2wou]], [[3hmm]], [[5usq]], [[3gxl]], [[5fri]], [[3tzm]], [[1vjy]], [[4x0m]], [[4x2f]], [[4x2g]], [[4x2j]], [[4x2k]], [[4x2n]], [[2x7o]], [[3faa]], [[3kcf]], [[1py5]], [[1rw8]] - hALK5 kinase domain + inhibitor<br /> | |||
**[[5e90]], [[5e91]], [[5qil]], [[5qik]], [[5qim]], [[6b8y]], [[5qu0]], [[5qtz]], [[5e8z]] - hALK5 kinase domain (mutant) + inhibitor<br /> | |||
**[[5e8x]], [[5e8w]] - hALK5 kinase domain (mutant) + staurosporine<br /> | |||
**[[5e92]] - hALK5 kinase domain (mutant) + AMPPNP<br /> | |||
**[[1b6c]] - hALK5 kinase domain + FKBP12<br /> | |||
*TGF-beta receptor type 2 or TGFR-2 | |||
**[[1m9z]] - hTGFR-2 LBD<br /> | |||
*TGF-beta receptor type 3 or TGFR-3 | |||
**[[4ajv]] - mTGFR-3 ZP-C domain 591-757<br /> | |||
**[[3qw9]] - rTGFR-3 ZP-C domain<br /> | |||
}} | }} | ||
== References == | == References == | ||
<references/> | <references/> |
Revision as of 13:36, 5 May 2020
|
3D structures of activin receptor3D structures of activin receptor
Updated on 05-May-2020
ReferencesReferences
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644